In Re Fosamax Products Liability Litigation

815 F. Supp. 2d 649, 2011 WL 4343215
District Court, S.D. New York·Decided September 15, 2011·No. 06 Civ. 6295(JFK); 06 MD 1789(JFK)·Published·Cited by 6 cases

Opinion

*650 MEMORANDUM OPINION AND ORDER

JOHN F. KEENAN, District Judge.

This is the fifth case selected for trial as a bellwether in the In re Fosamax Products Liability Litigation multidistrict litigation (“Fosamax MDL”). Plaintiff Sarah Raber (“Raber” or “Plaintiff’) moves for partial reconsideration of the Court’s Memorandum Opinion and Order dated April 27, 2011, which denied Raber’s request to withdraw her Lexecon waiver. Defendant Merck Sharp & Dohme Corp. (“Merck”) opposes the motion for reconsideration, arguing that Plaintiff has failed to comply with Rule 6.3 of the Joint Local Civil Rules of the United States District Courts for the Southern and Eastern Districts of New York (“L.C.R. 6.3”). In the alternative, Merck argues that Plaintiff has failed to show good cause to support her motion, and has provided inadequate documentation of the facts alleged in support of her motion. For the reasons set forth below, the motion for partial reconsideration is denied.

I. Background

On August 16, 2006, the United States Judicial Panel on Multidistrict Litigation transferred this case, along with seventeen other factually similar cases, to this Court for coordinated pretrial proceedings. See In re Fosamax Prods. Liab. Litig., 444 F.Supp.2d 1347, 1350 tb1.A (J.P.M.L.2006). Subsequently, scores of other cases were transferred to me as part of this multidistrict litigation docket.

As part of the Court’s case management plan for the Fosamax MDL, twenty-five cases were selected for trial as bellwethers. I directed the parties to select cases for expedited case-specific discovery, but cases filed in other federal district courts were eligible for inclusion in the bellwether trial pool only if the parties waived their right to trial in the transferor court. See Lexecon Inc. v. Milberg Weiss Bershad Hynes & Lerach, 523 U.S. 26, 28, 118 S.Ct. 956, 140 L.Ed.2d 62 (1998) (holding that a district court may not “invoke [28 U.S.C. § 1404(a) ] to assign a transferred case to itself for trial.”).

Originally, the Court planned to conduct three bellwether trials, but later directed Merck and the Plaintiffs’ Steering Committee (“PSC”) each to select an additional case for trial from the pool of twenty-five cases in which the parties had conducted case-specific discovery. The PSC selected Secrest v. Merck & Co., Inc., 06 Civ. 6292(JFK), and Merck selected Hester v. Merck & Co., Inc., 06 Civ. 9450(JFK). Secrest was originally scheduled for trial in February 2010, but was later adjourned until September 2011 and is on trial now. Hester was scheduled for trial in May 2010, but was voluntarily dismissed by the plaintiff prior to trial pursuant to Rule 41(a) of the Federal Rules of Civil Procedure. Merck’s first alternative selection was Raber v. Merck & Co., Inc., 06 Civ. 6295(JFK).

*651 After Hester was voluntarily dismissed, the PSC filed motions to withdraw each plaintiffs Lexecon waiver in Raber and Vandercar v. Merck & Co., Inc., 06 Civ. 11329(JFK), pursuant to Titles II and III of the Americans with Disabilities Act (“ADA”), 42 U.S.C. §§ 12101-213. 1 Though Raber’s case was originally filed in the United States District Court of the Middle District of Tennessee, the PSC sought withdrawal of her Lexecon waiver to permit the trial of Raber in the United States District Court for the Northern District of Florida. Because the bellwether selection process was designed to prevent the disclosure of each party’s alternative selections to the other party, the PSC had not been given notice that Merck had selected Raber as its first alternative to Hester when it filed the motions for withdrawal of the Lexecon waivers. On April 27, 2011, the Court denied the PSC’s motions for withdrawal of the Lexecon waivers and scheduled Raber for trial. See In re Fosamax Prods. Liab. Litig., No. 06 MD 1789, 2011 WL 1584584, at *2-3 (S.D.N.Y. Apr. 27, 2011) (“April 27 Order”). The Court ruled that the ADA did not provide a legal basis for the withdrawal of a Lexecon waiver, that a party seeking to withdraw a Lexecon waiver must show good cause for withdrawal, and that Plaintiff had failed to show good cause for withdrawal from her Lexecon waiver. Id. at *2 (citing Katel Ltd. Liab. Co. v. AT & T Corp., 607 F.3d 60, 66 (2d Cir.2010)). The Court ruled that plaintiff Reyna Vandercar’s request for withdrawal was premature because Vandercar had not been scheduled for trial. Id. at *3.

Thereafter, Raber moved pursuant to L.C.R. 6.3 for reconsideration of that part of the April 27 Order refusing to permit Raber to withdraw her Lexecon waiver.

II. Discussion

A. Compliance with Local Civil Rule 6.3

Under L.C.R. 6.3, a party seeking reconsideration of a district court’s ruling must “set[ ] forth concisely the matters or controlling decisions which counsel believes the court has overlooked.” The goal of Local Rule 6.3 is “to ensure the finality of decisions and to prevent the practice of a losing party examining a decision and then plugging the gaps of a lost motion with additional matters.” Grand Crossing, L.P. v. U.S. Underwriters Ins. Co., No. 03 Civ. 5429, 2008 WL 4525400, at *3 (S.D.N.Y. Oct. 6, 2008) (quotations omitted). Therefore, “[u]nder [L.C.R. 6.3], a party may not ‘advance new facts, issues or arguments not previously presented to the Court.’ ” E.E.O.C. v. Fed. Express Corp., 268 F.Supp.2d 192, 199 (E.D.N.Y.2003) (quoting Morse/Diesel, Inc. v. Fidelity & Deposit Co. of Md., 768 F.Supp. 115, 116 (S.D.N.Y.1991)). L.C.R. 6.3 affords relief where the court has erred by overlooking a factual or legal argument presented, not where a party failed to present relevant factual or legal arguments. Reconsideration is appropriate only where a court has overlooked controlling decisions *652 or facts presented in the underlying motion which, had they been considered, might reasonably have altered the result of the initial decision. See Shrader v. CSX Transp., Inc., 70 F.3d 255, 257 (2d Cir.1995).

Free access — add to your briefcase to read the full text and ask questions with AI

In Re Fosamax Products Liability Litigation, 815 F. Supp. 2d 649, 2011 WL 4343215 (S.D.N.Y. 2011).

815 F. Supp. 2d 649 (In Re Fosamax Products Liability Litigation) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

In re Libor-Based Financial Instruments Antitrust Litigation
27 F. Supp. 3d 447 (S.D. New York, 2014)
Plymouth County v. MERSCORP, Inc.
287 F.R.D. 449 (N.D. Iowa, 2012)
In re Optimal U.S. Litigation
886 F. Supp. 2d 298 (S.D. New York, 2012)